Physician profile
Lisa Torp
NPI 1043270036
$4,345.25
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $1,000 · 2021: $1,000 · 2022: $812 · 2023: $940 · 2024: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impedimed, INC. | $2,000.00 | 2020-2021 | |
| Sirius Medical Systems | $957.28 | 2023-2024 | Pintuition |
| Molli Surgical (US) INC | $660.62 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $175.96 | 2022-2024 | Enhertu |
| Siemens Medical Solutions USA, INC. | $170.84 | 2019 | |
| Medtronic, INC. | $157.49 | 2022-2023 | Plasmablade(Tm) |
| Merck Sharp & Dohme LLC | $120.82 | 2023 | Keytruda |
| Kerecis Limited | $67.70 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Myriad Genetic Laboratories, INC. | $22.23 | 2024 | Bracanalysis Cdx |
| Merit Medical Systems INC | $12.31 | 2024 | Savi Brachy, Savi Scout |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Torp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.